Cascadian Therapeutics, Inc. 4/A SEC Filings

Filed On	Filing
02 Apr 2015	Form 4/A: Spiegelman Daniel K, Director Bought 10,000 shares ($16.3K) · Bought 10,000 shares ($15.9K)
26 Sep 2014	Form 4/A: Venkatesan Jay, EVP and General Manager Bought 250,000 shares ($500K)
03 Dec 2010	Form 4/A: Christianson Gary, CHIEF OPERATING OFFICER Granted 50,000 Stock Option (right to buy)
03 Dec 2010	Form 4/A: Kirkman Robert L, Director Granted 100,000 Stock Option (right to buy)
21 Apr 2009	Form 4/A: Spiegelman Daniel K, Director Granted 19,352 Restricted Share Units
20 Apr 2009	Form 4/A: Stoughton W Vickery, Director Granted 19,352 Restricted Share Units
20 Apr 2009	Form 4/A: Jackson Richard L., Director Granted 19,352 Restricted Share Units
20 Apr 2009	Form 4/A: Henney Christopher S, Director Granted 19,352 Restricted Share Units
18 Mar 2009	Form 4/A: Christianson Gary, Chief Operating Officer Granted 30,000 Stock Option (right to buy)
18 Mar 2009	Form 4/A: Karan Shashi K., Corporate Controller Granted 7,500 Stock Option (right to buy)
18 Mar 2009	Form 4/A: Kirkman Robert L, Director Granted 100,000 Stock Option (right to buy)
11 Mar 2009	Form 4/A: Henney Christopher S, Director Granted 21,428 Restricted Share Units
11 Mar 2009	Form 4/A: Kirkman Robert L, Director Granted 100,000 Stock Option (right to buy)

Comments